Johnson & Johnson (J&J) reported better-than-expected adjusted earnings and revenue for the third quarter, showcasing strong performance in its pharmaceutical and medical devices bus… Read More

After Johnson & Johnson’s US Food and Drug Administration (FDA) approval last week for its second multiple myeloma bispecific, Talvey (talquetamab), Pfizer received an FDA nod for… Read More

In a world where health is paramount, the pharmaceutical industry stands as a formidable pillar, relentlessly pursuing scientific breakthroughs and life-saving innovations. With each passing… Read More

8 AL Amyloidosis patients relapsed/refractory to DARZALEX®-based regimens were treated with CAR-T NXC-201 100% (8/8) overall response rate and 63% (5/8) complete response (MRD 10-5) wa… Read More

Company Announcement COPENHAGEN, Denmark; April 21, 2023 – Genmab A/S (Nasdaq: GMAB) announced today an award in the second arbitration arising under its license agreement with Janss… Read More

Artur Widak | NurPhoto | Getty Images Johnson & Johnson reported adjusted earnings and revenue that topped Wall Street’s expectations on Tuesday, and lifted its full… Read More

Initial Phase 1b study results show clinical activity with immune-based triplet therapy regimen NEW ORLEANS, Dec. 10, 2022 /PRNewswire/ — The Janssen Pharmaceutical Companies of J… Read More

Johnson & Johnson beat earnings expectations in the last quarter of 2022, even as a strong US dollar and falling COVID-19 vaccine sales hurt earnings. The healthcare giant also released… Read More

Bharat Book Bureau Provides the Trending Market Research Report on “Global Bispecific Antibody Market Opportunity, Drug Sales, Price & Clinical Trials Insight 2028” under the… Read More

Dow jumped 284 but below early highs, advancers over decliners 4-1 & NAZ gained 72.  The MLP index added 2+ to the 216s & the REIT index was up 2+ to the 355s after yesterday's… Read More

During August, there was a considerable reduction in the number of short positions held in Genmab A/S (NASDAQ: GMAB). On August 15, there were 3,650,000 shares borrowed; as of August 31, the… Read More

Kenneth Research has evaluated the current market opportunities in Oncology Cancer Blockbuster Drugs Market in the healthcare industry for the forecast period 2022-2031, which… Read More

Drug delivery technologies improve the efficacy and safety of a drug by controlling the rate, time, and place of drug release in the body. This market is highly competitive and is witnessi… Read More

According to the analysis, the below factors are playing a key role in shaping the growth of the global Pharmaceutical Drug Delivery Market: # Due to the rapid spread of COVID… Read More

About the Report:Drug delivery is the method or process of administration of a pharmaceutical drug to safely attain its desired therapeutic effect. Advancements in drug delivery technologies… Read More

Boyd Huppert multiple myeloma or simply multiple myeloma is one of the rare kinds of cancer that develops in the plasma cells, a subtype of your WBCs. Plasma cells are present mainly in the… Read More

Johnson & Johnson: स्वास्थ्य उत्पादों की दिग्… Read More

 Orphan Drugs Market Research Report: Information by Drug Type (Biologics & Non-Biologics), Sale (Generics & Prescribed), Drug (Revlimid, Rituxan, Opdivo, & Others), Therapy… Read More

The global orphan drugs market is expected to exhibit a strong 11.50% CAGR over the forecast period from 2018 to 2023, according to the latest research report from Market Research Future (MR… Read More

The global orphan drugs market is expected to exhibit a strong 11.50% CAGR over the forecast period from 2018 to 2023, according to the latest research report from Market Research Future (MR… Read More

The Janssen Pharmaceutical Companies of Johnson & Johnson today announced results from the Phase 3 Read More

Not even close, doing pretty well actually, though I should post more often. I was diagnosed with myeloma in July, 2003, and according to my math that's well over 16 years ago. My family and… Read More

Chronic Lymphocytic Leukemia Treatment options for multiple myeloma have grown a good understanding in a past few years. Newly authorized drugs assistance people with this blood cancer now… Read More